Cytomegalovirus infection after prophylactic valganciclovir therapy post-kidney transplantation: case reports.
This report describes three patients who developed cytomegalovirus infection 4 months after high-risk donor+/recipient-(D+/R-) kidney transplantation, despite treatment with valgancyclovir (VGCV) for 3 months at low dose (450 mg/d).